• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • The future of US Aid

    USAID extends HIV supply chain project by two years

    Last week, USAID published its justification for extending the HIV component of its global health supply chain project — led by Chemonics International — for another two years and roughly $2 billion more in funding.

    By Michael Igoe // 18 June 2024
    Faced with the “massive endeavor” of replacing its global health supply chain project with a new collection of contracts, USAID has decided to extend the current portion of the project that handles HIV commodities for an additional two years and roughly $2 billion more in funding. USAID’s Bureau of Global Health proposed the extension late last year, requesting approval of a contract modification that will keep Chemonics International at the helm of the HIV supply chain until November 2026. Chemonics has led USAID’s global health supply chain efforts since 2016 after it was awarded a $9.5 billion contract whose design and implementation later faced criticism from Congress, independent watchdogs, and some U.S. global health officials. The request to extend one of the largest pieces of that contract was approved in January, and the document outlining USAID’s justification for extending the contract without an open competition was published online last week. The justification — sent by Atul Gawande, USAID’s assistant administrator for global health — underscores the life-or-death stakes of the global health supply chain, USAID’s cautious approach to transitioning from its current contracts to the new ones, and the agency’s view that neither country governments nor other contractors are capable of bridging the gap. “If the flow of life-saving commodities or the provision of supply chain technical assistance is suspended without a viable alternative, millions of people living with HIV will not have access to antiretroviral treatment, pre-exposure prophylaxis, essential medicines, and diagnostic and testing tools for viral load and early infant diagnostics,” Gawande wrote. USAID’s years-long process of designing and awarding the new global health supply chain contract — a roughly $17 billion effort known as NextGen — has been closely scrutinized. Last month Sen. Ben Cardin, a Democrat from Maryland and chair of the U.S. Senate Foreign Relations Committee, wrote a letter to USAID Administrator Samantha Power pressing her to disclose what percentage of NextGen’s funding would go to local and private sector organizations. USAID initially indicated it would award all of the NextGen supply chain contracts in 2021, but has so far awarded only two of an expected nine contracts. The new timeline means that the transition from the current supply chain project to NextGen will likely span three presidential terms of office. USAID did not respond to an inquiry from Devex. In his request for approval to extend the current HIV-related portion — known as a “task order” — Gawande emphasized that USAID is committed to ensuring 12 to 18 months of overlap between the current contracts and the new ones to mitigate problems in the transition. Gawande wrote that the need for such overlap has been repeatedly highlighted by oversight bodies and was a “critical lesson” from the previous transition. “The design and procurement of NextGen is a massive endeavor with nine separate contracts that interrelate and need to be synchronized,” Gawande wrote. The transition from the current project to NextGen will be “staggered,” he added, with the current project winding down activities whenever NextGen-funded projects can take over. Gawande wrote that USAID considered at least one option other than extending the current contract with Chemonics. “USAID considered the option of awarding a bridge contract using full and open competition, which would allow the Agency to obtain additional value or better contractual terms, but concluded that this is not a viable alternative,” Gawande wrote, citing the risk of undertaking “multiple transitions” and the “cost of start-up and close-out of a new contract in such a short period of time.” “Regarding in-country supply chains, particularly those that are fragile and/or need assistance to manage their health systems, country governments may be unable to fill funding gaps provided by the [U.S. government],” he wrote. In lieu of other options, the approved extension will raise the current task order’s ceiling by over $2 billion and increase the “level of effort” for field operations by 2.8 million hours.

    Faced with the “massive endeavor” of replacing its global health supply chain project with a new collection of contracts, USAID has decided to extend the current portion of the project that handles HIV commodities for an additional two years and roughly $2 billion more in funding.

    USAID’s Bureau of Global Health proposed the extension late last year, requesting approval of a contract modification that will keep Chemonics International at the helm of the HIV supply chain until November 2026. Chemonics has led USAID’s global health supply chain efforts since 2016 after it was awarded a $9.5 billion contract whose design and implementation later faced criticism from Congress, independent watchdogs, and some U.S. global health officials.

    The request to extend one of the largest pieces of that contract was approved in January, and the document outlining USAID’s justification for extending the contract without an open competition was published online last week.

    This story is forDevex Promembers

    Unlock this story now with a 15-day free trial of Devex Pro.

    With a Devex Pro subscription you'll get access to deeper analysis and exclusive insights from our reporters and analysts.

    Start my free trialRequest a group subscription
    Already a user? Sign in
    • Funding
    • Democracy, Human Rights & Governance
    • Humanitarian Aid
    • Private Sector
    • Global Health
    • Institutional Development
    • Trade & Policy
    • United States Agency for International Development (USAID)
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
    Should your team be reading this?
    Contact us about a group subscription to Pro.

    About the author

    • Michael Igoe

      Michael Igoe@AlterIgoe

      Michael Igoe is a Senior Reporter with Devex, based in Washington, D.C. He covers U.S. foreign aid, global health, climate change, and development finance. Prior to joining Devex, Michael researched water management and climate change adaptation in post-Soviet Central Asia, where he also wrote for EurasiaNet. Michael earned his bachelor's degree from Bowdoin College, where he majored in Russian, and his master’s degree from the University of Montana, where he studied international conservation and development.

    Search for articles

    Related Jobs

    • International Team Leader
      Uzbekistan | Central Asia
    • Safeguarding Manager (Fixed-term) (Hybrid)
      London, United Kingdom | United Kingdom | Western Europe
    • Mobile Implementation Officer (MIO) (Fixed-term)
      Worldwide
    • See more

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      FCDO's top development contractors in 2024/25
    • 3
      How AI-powered citizen science can be a catalyst for the SDGs
    • 4
      Opinion: The missing piece in inclusive education
    • 5
      Strengthening health systems by measuring what really matters

    Trending

    Financing for Development Conference

    The Trump Effect

    Newsletters

    Related Stories

    Devex CheckUpDevex CheckUp: Our most-read global health stories of 2024

    Devex CheckUp: Our most-read global health stories of 2024

    The future of US aidExclusive: Don’t email us, we’ve got very few answers, USAID staff told

    Exclusive: Don’t email us, we’ve got very few answers, USAID staff told

    The Future of US AidWho lost the most? The 20 USAID contractors hit hardest

    Who lost the most? The 20 USAID contractors hit hardest

    Global Health ‘What’s in’ and ‘what’s out’ in USAID’s global health programming

    ‘What’s in’ and ‘what’s out’ in USAID’s global health programming

    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement